PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders

American Journal of Psychiatry

Volumn 156, Issue 12, 1999, Pages 1871-1878

  Meltzer, Carolyn Cidis ^a   Price, Julie C ^b   Mathis, Chester A ^b   Greer, Phil J ^b   Cantwell, Michael N ^b   Houck, Patricia R ^b   Mulsant, Benoit H ^b   Ben Eliezer, Doron ^b   Lopresti, Brian ^b   DeKosky, Steven T ^b   Reynolds III, Charles F ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN 2A RECEPTOR;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; NEUROPSYCHIATRY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY;

AGE FACTORS; AGED; ALZHEIMER DISEASE; BRAIN; CEREBRAL CORTEX; DEPRESSIVE DISORDER; FEMALE; FLUORINE RADIOISOTOPES; GYRUS CINGULI; HUMANS; KETANSERIN; MAGNETIC RESONANCE IMAGING; MALE; PREFRONTAL CORTEX; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032697987     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Devanand D, Sano M, Tang M-X, Taylor S, Gurland B, Wilder D, Stern Y, Mayneux R: Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996; 53:175-182
2. Komahashi T, Ohmori K, Nakano T, Fujinuma H, Higashimoto T, Nakaya M, Kuroda J, Asahi M, Yoshikawa J, Mastumura S: Epidemiological survey of dementia and depression among the aged living in the community in Japan. Jpn J Psychiatry Neurol 1994; 48:517-526
3. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990;47:1038-1047
4. 2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 1989; 146: 730-736
5. 2 receptor indices to major depressive disorder, personality traits, and suicidal behavior. Biol Psychiatry 1994; 35:295-308
6. Blier P, de Montigny C, Chaput Y: A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 1990; 51 (April suppl): 14-20
7. Cross AJ: Serotonin in Alzheimer-type dementia and other dementing illness. Ann NY Acad Sci 1990; 600:405-417
8. Cheng AVT, Ferrier IN, Morris CM, Jabeen S, Sahgal A, McKeith IG, Edwardson JA, Perry RH, Perry EK: Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. J Neurol Sci 1991; 106:50-55
9. Bowen DM, Allen SJ, Benton JS, Goodhardt MJ, Haan EA, Palmer AM, Sims NR, Smith CCT, Spillane JA, Esiri MM, Neary D, Snowdon JS, Wilcock GK, Davison AN: Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem 1983; 41:266-272
10. Nordberg A: Neuroreceptor changes in Alzheimer disease. Cerebrovasc Brain Metab Rev 1992; 4:303-328
11. Bowen DM, Najlerahim A, Procter A, Francis P, Murphy E: Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of late life. Proc Natl Acad Sci USA 1989; 86: 9504-9508
12. Blin J, Baron JC, Dubois B, Crouzel C, Fiorelli M, Attar-Levy D, Pillon B, Fournier D, Vidailhet M, Agid Y: Loss of brain 5HT2 receptors in Alzheimer's disease. Brain 1993; 116:497-510
13. Biver F, Wikler D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J: Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry 1997; 171:444-448
14. Marcusson J, Morgan D, Winblad B, Finch C: Serotonin-2 binding sites in human frontal cortex and hippocampus: selective loss of S-2A sites with age. Brain Res 1984; 311:51-56
15. 2 receptor binding sites in depressed suicide victims. Brain Res 1988; 443:272-280
16. Sparks D: Aging and Alzheimer's disease: altered cortical serotonergic binding. Arch Neurol 1989; 46:138-140
17. 3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Res 1990; 507:208-215
18. Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J: Effect of aging in human cortical pre-and postsynaptic serotonin binding sites. Brain Res 1993; 620:163-166
19. 18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Res 1998; 813:167-171
20. 18F] and positron emission tomographic imaging. Psychiatr Res 1996; 68:11-22
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
22. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
23. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
24. Mattis S: Mattis Organic Mental Syndrome Screening Examination (MOMSSE), in Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. Edited by Bellak L, Karasu TB. New York, Grune & Stratton, 1976, pp 102-177
25. Lemaire C, Cantineau R, Guillaume M, Plenevaux A, Christiaens L: Fluorine-18 altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. J Nucl Med 1991; 32:2266-2272
26. Sandor S, Leahy R: Surface based labelling of cortical anatomy using a deformable atlas. IEEE Trans Med Imaging 1997; 16:41-54
27. Woods RP, Mazziotta JC, Cherry SR: MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17: 536-546
28. Wiseman M, Nichols T, Woods R, Sweeney J, Mintun M: Stereotaxic techniques comparing foci intensity and location of activation areas in the brain as obtained using positron emission tomography (PET) (abstract). J Nucl Med 1995; 36(May suppl):93P
29. 2 receptors in depression. Psychiatr Res Neuroimaging 1992; 45:227-237
30. Pazos A, Probst A, Palacios JM: Serotonin receptors in the human brain, IV: autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987; 21:123-139
31. Smith GS, Price JC, Lopresti BJ, Huang Y, Simpson N, Holt D, Mason NS, Meltzer CC, Sweet RA, Nichols T, Sashin D, Mathis CA: Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F] altanserin in the human brain. Synapse 1998; 30:380-392
32. Price J, Lopresti B, Mason NS, Huang Y, Holt D, Smith G, Mathis CA: [18F]Altanserin PET studies of serotonin-2A binding: examination of nonspecific component, in Quantitative Brain Imaging With Positron Emission Tomography. Edited by Carson R, Daube-Witherspoon M, Herscovitch P. San Diego, Academic Press, 1998, pp 441-448
33. Mason N, Huang Y, Holt D, Perevuznik J, Lopresti B, Mathis C: Synthesis and characterization of [F-18]4-(4-fluoro-benzoyl)piperidine, an [F-18]altanserin metabolite (abstract). J Nucl Med 1997; 38(May suppl):56P
34. Lopresti B, Holt D, Mason S, Huang Y, Ruszkiewicz J, Perevuznik J, Price J, Smith G, Mathis C: Characterization of the radiolabeled metabolites of [18F]altanserin: implications for kinetic modeling, in Quantitative Brain Imaging With Positron Emission Tomography. Edited by Carson R, Daube-Witherspoon M, Herscovitch P. San Diego, Academic Press, 1998, pp 293-298
35. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 1994; 14:995-1010
36. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990; 10:740-747
37. Sadzot B, Lemaire C, Maquet P, Salmon E, Plenevaux A, Degueldre C, Hermanne J, Guillaume M, Cantineau R, Comar D, Franck G: Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls. J Cereb Blood Flow Metab 1995; 15:787-797
38. Biver F, Goldman S, Luxen A, Monclus M, Forestini M, Mendlewicz J, Lotstra F: Multicompartmental study of fluorine-1B altanserin binding to brain 5HT2 receptors in humans using positron emission tomography. Eur J Nucl Med 1994; 21: 937-946
39. Chawluk JB, Alavi A, Dann R, Hurtig HI, Bais S, Kushner MJ, Zimmerman RA, Reivich M: Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med 1987;28:431-437
40. Erkinjuntti T, Lee DH, Gao F, Steenhuis R, Eliasziw M, Fry R, Merskey H, Hachinski VC: Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol 1993; 50:305-310
41. Alexopoulos G, Young R, Shindledecker R: Brain computed tomography findings in geriatric depression and primary degenerative dementia. Biol Psychiatry 1992; 31:591-599
42. Beats B, Levy R, Forstl H: Ventricular enlargement and caudate hyperdensity in elderly depressives. Biol Psychiatry 1991;30:452-458
43. Kumar A, Miller D, Ewbank D, Yousem D, Newberg A, Samuels S, Cowell P, Gottlieb B: Quantitative anatomic measures and comorbid medical illness in late-life major depression. Am J Geriatr Psychiatry 1997; 5:15-25
44. Meltzer CC, Leal JP, Mayberg HS, Wagner HJ, Frost JJ: Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr 1990; 14:561-570
45. 2 sites in cortex and amygdala. Brain Res 1993; 614:37-44
46. Biver F, Lotstra F, Monclus M, Wikler D, Damhaut P, Mendlewicz J, Goldman S: Sex difference in 5HT2 receptors in the living human brain. Neurosci Lett 1996; 204:25-28
47. Diksic M, Benkelfat C, Nishizawa S, Mzengeza S, Leyton M, Blier P, de Montigny C, Young S: Brain serotonin synthesis is differentially affected in males and females by reduction in plasma tryptophan (abstract). J Nucl Med 1996; 37(May suppl):284P
48. McBride P, Tierney H, DeMeo M, Chen J-S, Mann J: Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 1990; 27:1143-1155
49. Zhang L, Ma W, Barker J, Rubinow D: Sexual differences in mRNA expression and binding distribution of 5-HT1A and 5-HT2 receptors in rat hippocampus. Abstracts of the Society for Neuroscience 1994; 21:1548
50. Gonzales G, Carillo C: Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels. Maturitas 1993; 17:23-29
51. Crow TJ, Cross AJ, Cooper SJ, Deakin JF, Ferrier IN, Johnson JA, Joseph MH, Owen F, Poulter M, Lofthouse R, Corsellis J, Chambers D, Blessed G, Perry E, Perry R, Tomlinson B: Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology 1984; 23:1561-1569
52. Cross AJ, Crow TJ, Ferrier IN, Johnson JA, Bloom SR, Corsellis JAN: Serotonin receptor changes in dementia of the Alzheimer type. J Neurochem 1984; 43:1574-1581
53. Cowen PJ: Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin Neuropharmacol 1993; 16(suppl 3):S6-S18
54. Stockmeier C, Dilley G, Shapiro L, Overholser J, Thompson P, Meltzer H: Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 1996; 16:162-173
55. 2 receptors and suicide (letter). Lancet 1983; 2:1256
56. Owen F, Chambers DR, Cooper SJ, Crow TJ, Johnson JA, Lofthouse R, Poulter M: Serotonergic mechanisms in brains of suicide victims. Brain Res 1986; 362:185-188